Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients
Clinical trial NCT02642458 · UNKNOWN
Trial details
- NCT number
- NCT02642458
- Sponsor
- University Hospital Tuebingen
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-03-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.